Shao-Lee Lin

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Agoura Hills, CA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Shao-Lee Lin
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Shao-Lee Lin

Form 4 holding Chief Executive Officer, Director

ACELYRIN, Inc.

Security class
Common Stock
Shares / value
1,577,374
Estimated value
$10,455,308
Report date
01 Apr 2024
Price
$6.63
Ownership
Direct
Form 4 holding Chief Executive Officer, Director

ACELYRIN, Inc.

Security class
Common Stock
Shares / value
5,070
Estimated value
$33,605
Report date
01 Apr 2024
Price
$6.63
Ownership
Indirect
Form 4 holding Chief Executive Officer, Director

Cue Biopharma, Inc.

Security class
Stock Option (right to buy)
Shares / value
655,074
Estimated value
Report date
03 May 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Chief Executive Officer, Director

ACELYRIN, Inc.

Security class
Employee Stock Option (right to buy)
Shares / value
413,498
Estimated value
Report date
09 Jan 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Chief Executive Officer, Director

Cue Biopharma, Inc.

Security class
Pre-Funded Warrants (Right to Buy)
Shares / value
90,906
Estimated value
Report date
01 Jun 2026
Price
Ownership
Indirect
Underlying class
Common Stock
Underlying amount
Form 4 holding Chief Executive Officer, Director

Cue Biopharma, Inc.

Security class
Common Stock Warrants (Right to Buy)
Shares / value
45,453
Estimated value
Report date
01 Jun 2026
Price
Ownership
Indirect
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Third Harmonic Bio, Inc.

Security class
Stock Option (right to buy)
Shares / value
13,667
Estimated value
Report date
26 Oct 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Surrozen, Inc./DE

Security class
Option (right to buy)
Shares / value
1,333
Estimated value
Report date
14 May 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Surrozen, Inc./DE

Security class
Option (right to buy)
Shares / value
1,333
Estimated value
Report date
05 Jun 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Shao-Lee Lin

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .